Skip to main content
INTS logo

INTS · Intensity Therapeutics, Inc.

$4.43 +0.04 (+0.91%) At close · Jul 23
Market Cap
$11.97M
Shares
2.70M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
59/100
Short interest 6.0% of shares — P77 Days to cover 3.0 — P47 Price vs VWAP -0.3% — P56 Short-volume trend -21.2% — P4 Short interest change +28.6% — P86 Worst FTD 0.29% of shares — P86

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-07-15 162,597 126,421 +36,176 3.02
2026-06-30 126,421 58,214 +68,207 1.66
2026-06-15 58,214 75,310 -17,096 1.69
2026-05-29 75,310 75,334 -24 3.65
2026-05-15 75,334 72,900 +2,434 2.45
2026-04-30 72,900 65,989 +6,911 2.08
2026-04-15 65,989 61,082 +4,907 2.71
2026-03-31 61,082 52,723 +8,359 2.57
2026-03-13 52,723 71,994 -19,271 1.72
2026-02-27 71,994 1,077,181 -1,005,187 1.00
2026-02-13 43,087 46,341 -3,254 1.00
2026-01-30 46,341 59,035 -12,693 1.00
2026-01-15 59,035 74,616 -15,581 1.40
2025-12-31 74,616 117,849 -43,233 1.21
2025-12-15 117,849 100,304 +17,545 1.00
2025-11-28 100,304 143,531 -43,227 1.53
2025-11-14 143,531 670,771 -527,240 1.00
2025-10-31 670,771 90,160 +580,611 1.00
2025-10-15 90,160 34,638 +55,522 1.00
2025-09-30 34,638 10,171 +24,467 1.00
2025-09-15 10,171 26,834 -16,663 1.00
2025-08-29 26,834 39,515 -12,680 1.00
2025-08-15 39,515 37,802 +1,712 1.00
2025-07-31 37,802 15,498 +22,305 1.00
Showing 1–24 of 24 settlements
Key facts CIK 1567264 CUSIP 45828J202 13F (30d) 3 filings 3 filers Visit website Investor relations